Provention Bio Announces Completion of $35 Million Equity Investment from Sanofi US

/PRNewswire/ -- Provention Bio, Inc. (Nasdaq: PRVB) (the "Company"), a biopharmaceutical company dedicated to intercepting and preventing immune-mediated...

Related Keywords

United States ,Thierry Chauche ,Jason Hoitt ,Olivier Bogillot ,Provention Bio ,Provention Bio Inc ,Twitter ,Provention Bio Patient Assistance Program ,Nasdaq ,Trademark Office ,Exchange Commission ,Prnewswire Provention Bio Inc ,Sanofi Us Co ,Provention Bio Copay Program ,Co Promotion Agreement ,Securities Purchase Agreement ,Chief Commercial Officer ,Purchase Agreement ,Patient Assistance Program ,Safety Information ,Release Syndrome ,Hypersensitivity Reactions ,United States Patent ,Chief Financial ,Nc ,